Found: 15
Select item for more details and to access through your institution.
Association Between Plasma Proprotein Convertase Subtilisin/Kexin Type 9 and the Presence of Metabolic Syndrome in a Predominantly Rural-Based Sub-Saharan African Population.
- Published in:
- Metabolic Syndrome & Related Disorders, 2017, v. 15, n. 8, p. 423, doi. 10.1089/met.2017.0027
- By:
- Publication type:
- Article
Dysbetalipoproteinemia Is Associated With Increased Risk of Coronary and Peripheral Vascular Disease.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 1, p. 184, doi. 10.1210/clinem/dgac503
- By:
- Publication type:
- Article
Dysbetalipoproteinemia: Differentiating Multifactorial Remnant Cholesterol Disease From Genetic ApoE Deficiency.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 2, p. 538, doi. 10.1210/clinem/dgab648
- By:
- Publication type:
- Article
Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Two Cases of Sitosterolemia Falsely Diagnosed as Familial Hypercholesterolemia: Could Digging Deeper Have Avoided Harm?
- Published in:
- JCEM Case Reports, 2024, v. 2, n. 5, p. 1, doi. 10.1210/jcemcr/luae086
- By:
- Publication type:
- Article
Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1455, doi. 10.1111/dom.13680
- By:
- Publication type:
- Article
Validation of the Fatty Liver Index for identifying non‐alcoholic fatty liver disease in a Kenyan population.
- Published in:
- Tropical Medicine & International Health, 2023, v. 28, n. 10, p. 830, doi. 10.1111/tmi.13927
- By:
- Publication type:
- Article
Hepatic steatosis is associated with anthropometry, cardio‐metabolic disease risk, sex, age and urbanisation, but not with ethnicity in adult Kenyans.
- Published in:
- Tropical Medicine & International Health, 2022, v. 27, n. 1, p. 49, doi. 10.1111/tmi.13696
- By:
- Publication type:
- Article
Molecular Characterization of Familial Hypercholesterolemia in a North American Cohort.
- Published in:
- Journal of the Endocrine Society, 2020, v. 4, n. 1, p. N.PAG, doi. 10.1210/jendso/bvz015
- By:
- Publication type:
- Article
Loss-of-Function PCSK9 Mutations Are Not Associated With Alzheimer Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe.
- Published in:
- Clinical Chemistry, 2018, v. 64, n. 2, p. 355, doi. 10.1373/clinchem.2017.279422
- By:
- Publication type:
- Article
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9): Lessons Learned from Patients with Hypercholesterolemia.
- Published in:
- Clinical Chemistry, 2014, v. 60, n. 11, p. 1380, doi. 10.1373/clinchem.2014.225946
- By:
- Publication type:
- Article
Effect of the LDL receptor mutation type on incident major adverse cardiovascular events in familial hypercholesterolaemia.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 16, p. 2125, doi. 10.1093/eurjpc/zwac188
- By:
- Publication type:
- Article
Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene.
- Published in:
- Clinical Genetics, 2022, v. 102, n. 4, p. 253, doi. 10.1111/cge.14185
- By:
- Publication type:
- Article
Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trial.
- Published in:
- Clinical Cardiology, 2018, v. 41, n. 9, p. 1117, doi. 10.1002/clc.23018
- By:
- Publication type:
- Article